Infographic | HCPs OK with emails from marketers
HCPs are still OK with hearing from pharma and medical device marketers as long as it’s by email.
Data/Analytics
Ketchum launches Vital Health, analytics-driven services for healthcare clients
Vital Health is driven by Ketchum’s new analytics tool, Vital Diagnostics.
Who’s your prescriber now? Demand for NPs and PAs is booming, according to report
Recent healthcare trends, including a physician shortage and the rise of value-based care centers, have put NPs and PAs on the fast track to recruiter popularity. Marketers, take note.
Infographic | MSLs by the numbers
Medical science liaisons are essential participants in most aspects of the commercialization process.
How data regulation could be good for marketing post-Cambridge Analytica
Stuart Ingis on the benefits of showing the public how advertisers and marketers use data and creating a global regulatory framework.
Former FDA commissioner Califf to pharma: opening up on health data requires overcoming risk
Califf spoke about the importance of more data to faster and cheaper drug development at the NewYorkBIO conference.
Trust in health sector takes a hit in major markets, Edelman research finds
The healthcare sector has suffered a dip in public trust in major markets including France, India and the US, but Britons remain among the more trusting globally, according to the Edelman Health Trust Barometer.
Infographic | A closer look at co-pay coupons and programs
Intriguing data on the economics and impact of co-pay coupons and programs
The Cambridge Analytica mess: What does it mean for pharma?
What happens in the world of Facebook cannot be ignored in pharma marketing. It increasingly lives in a world of data that is highly sensitive and must be managed well.
In [Insert Company Here] We Trust?
Whether it’s data or marketing dollars, there should be no surprises when you partner with a company.
Want to read more?
Please login or register first to view this content.
